Leflunomide is the only nonbiologic DMARD developed specifically for the treatment of RA. It is an isoxazole derivative and its active metabolite, teriflunomide (formerly known as A77 1726), acts ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.

Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, ...

New, effective treatments for RA and new conceptual approaches have led to a shift in practice, with an emphasis now on treating arthritis as early as possible to a defined target where possible ...

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.

Objectives To assess the effect of treatment on haemostatic parameters in patients with early rheumatoid arthritis (RA).

Study to determine which treatments best for which inflammatory arthritis patients should result in patients being better ...

Rheumatoid arthritis (RA) can be a challenging and ... Or, your doctor might add the biologic to your current treatment plan. Taking multiple biologics at the same time may increase your risk ...

Now a growing number of experts, as well as new European guidelines, recommend expanding treatment criteria to allow more people with rheumatoid arthritis to take statins. (Prescribing a statin to ...